Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-7,500
Closed -$321K 232
2017
Q4
$321K Sell
7,500
-7,500
-50% -$299K ﹤0.01% 225
2017
Q3
$550K Buy
15,000
+10,000
+200% +$404K 0.02% 159
2017
Q2
$227K Hold
5,000
0.01% 270
2017
Q1
$213K Buy
+5,000
New +$204K 0.01% 206
2014
Q4
Sell
-188,861
Closed -$4.59M 259
2014
Q3
$4.59M Buy
188,861
+26,345
+16% +$665K 0.47% 43
2014
Q2
$4.12M Buy
162,516
+144,805
+818% +$3.38M 0.46% 51
2014
Q1
$381K Sell
17,711
-4,788
-21% -$103K 0.05% 147
2013
Q4
$503K Buy
+22,499
New +$496K 0.08% 165

Other funds holding HOLX

Cowen Inc's HOLX Position: Q1 2018 in Review

Cowen Inc sold out of Hologic (HOLX) in Q1 2018, closing a stake of 7,500 shares — an estimated $321K sold.

Cowen Inc first reported a position in HOLX in Q4 2013 and held it in 8 quarters. The position peaked at $4.59M in Q3 2014. 463 funds tracked by Wall St. Rank hold HOLX as of Q1 2018.

  • Cowen Inc reported no remaining Hologic position as of Q1 2018 after selling out during the quarter.
  • Cowen Inc sold 7,500 Hologic shares in Q1 2018, an estimated $321K.
  • Cowen Inc first reported a position in Hologic in Q4 2013 and held it in 8 quarters.
  • Cowen Inc's Hologic position peaked at $4.59M in Q3 2014.
  • 463 funds tracked by Wall St. Rank held Hologic as of Q1 2018.

Based on Cowen Inc's 13F filing for Q1 2018, filed 15 May 2018.